The Nigeria Centre for Disease Control (NCDC) has noted its evaluation of the risk concerning the Human Metapneumo Virus (HMPV) in the nation, which it categorizes as moderate. HMPV is a species of single-stranded ribonucleic acid virus noted for its immunogenic properties leading to symptoms akin to that of the common cold and influenza. These symptoms can range vastly from coughs, fever, and nasal congestion to fatigue, with an incubation period spanning three to six days.
In recent times, HMPV has come to the forefront of global health concerns with an outbreak in China and documented cases in India. In light of this, the NCDC has been vigilantly observing international health developments and have taken necessary actions to maintain public health safety. This has been achieved through a dynamic risk assessment procedure for HMPV, which involved collaboration with a number of health organizations such as the WHO, USCDC, and the UKHSA among others.
The dynamically assessed risk of HMPV for Nigeria currently stands as moderate, as stated by the Director General of NCDC, Dr. Jide Idris. This evaluation assists in the provision of valuable data to make informed decisions and develop appropriate response strategies to mitigate prospective impacts. To further aid public awareness and safety, a public health advisory has been circulated to Nigerians, providing updated information on necessary preparatory actions and preventive measures.
This advisory also highlights the NCDC’s collaboration with the Port Health Authorities to ensure a heightened level of preparedness at all international Points of Entry. In addition to this, hospitals nationwide have been advised on elevated Infection Prevention and Control practices, such as proper hand hygiene, environmental cleaning, respiratory hygiene, and cough etiquette. The provision of an isolation room in all health facilities for quick quarantining of cases while receiving care has been made a mandatory requirement.
The NCDC has also taken necessary precautions to readily cater to any potential outbreak by accumulating relevant materials such as Personal Protective Equipment (PPE), in addition to other essential IPC items. Moreover, necessary laboratory supplies and reagents have been stockpiled to ensure swift response times.
As an infection prevention professional, it’s critical to note the symptoms of HMPV. These include cough, fever, nasal congestion, wheezing, bronchitis, or pneumonia. It has been found that vulnerable groups such as very young children, older people, and patients with low immunity or on treatments such as cancer therapies or uncontrolled diabetes are particularly susceptible. The incubation period post-exposure is typically 3-5 days, and infections usually resolve within 2-5 days with supportive care. However, high-risk groups may experience complications.
Furthermore, we know that HMPV spreads through respiratory droplets from coughing and sneezing and close personal contact, which emphasizes the importance of adherence to outlined preventive measures.
The NCDC has made it clear that it stands fast in its commitment to ensure the health of Nigerians through continuous surveillance and prompt responses to infectious diseases. Healthcare professionals are encouraged to remain up-to-date and to inform patients about the suggested preventive measures and critical import of seeking immediate medical attention if they experience symptoms consistent with HMPV infection.
Source: https://thewillnews.com/ncdc-rates-nigerias-risk-of-hmpv-as-moderate-announces-preventive-measures/